Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Brain Neoplasms 3Meningeal Carcinomatosis 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

trastuzumab deruxtecan 1omburtamab I-131 1merphos 1epothilone B 1adavosertib 1XL647 1Transplantation, Autologous 1Sorafenib 1Rituximab 1Radiotherapy 1Radiation 1Nivolumab 1Methotrexate 1Ipilimumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Meningeal Carcinomatosis × XL647 × Clear all
NCT02616393 2022-03-16

Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases

Kadmon Corporation, LLC

Phase 2 Completed
36 enrolled 22 charts
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡